Rho GTPases in pulmonary vascular dysfunction (Q38043896)

27 August 2017

title

Rho GTPases in pulmonary vascular dysfunction (English)

1 reference

27 August 2017

Elisabeth M Storck

1 reference

27 August 2017

Beata Wojciak-Stothard

series ordinal

1 reference

27 August 2017

publication date

13 September 2012

1 reference

27 August 2017

published in

Vascular Pharmacology

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

202-210

1 reference

Hypoxic pulmonary vasoconstriction: mechanisms and controversies

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

The Lbc Rho guanine nucleotide exchange factor α-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Driving Rho GTPase activity in endothelial cells regulates barrier integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Biology of the p21-activated kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Microparticles: An Introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Chronic hypoxia augments depolarization-induced Ca2+ sensitization in pulmonary vascular smooth muscle through superoxide-dependent stimulation of RhoA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

What tangled webs they weave: Rho-GTPase control of angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Endothelial dysfunction in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Postnatal maturational shift from PKCzeta and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Key role of the RhoA/Rho kinase system in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Activation of PAK1/2 during the shedding of platelet microvesicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Regulation of lymphatic-blood vessel separation by endothelial Rac1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Reciprocal regulation of Rac1 and PAK-1 by HIF-1alpha: a positive-feedback loop promoting pulmonary vascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rac regulates thrombin-induced tissue factor expression in pulmonary artery smooth muscle cells involving the nuclear factor-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Recent Progress in the Management of Pulmonary Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Iron-induced remodeling in cultured rat pulmonary artery endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Circulating Endothelial Microparticles as a Measure of Early Lung Destruction in Cigarette Smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho GTPases and the Actin Cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho and Ras GTPases in axon growth, guidance, and branching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

All ras proteins are polyisoprenylated but only some are palmitoylated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Hypertension caused by transgenic overexpression of Rac1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Multiple roles for RhoA during T cell transendothelial migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

7 January 2021

Redox regulation of RhoA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Regulation of NADPH oxidases: the role of Rac proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoB regulates PDGFR-beta trafficking and signaling in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoB links PDGF signaling to cell migration by coordinating activation and localization of Cdc42 and Rac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Genetics of pulmonary hypertension: from bench to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho GTPases: biochemistry and biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Role of src-family kinases in hypoxic vasoconstriction of rat pulmonary artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

The role of circulating serotonin in the development of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Direct vascular effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Role of Rac1 in a bleomycin‐induced scleroderma model using fibroblast‐specific Rac1‐knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

The role of Rho protein signaling in hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Regulation of Rho proteins by phosphorylation in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

The endothelium in acute lung injury/acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Microparticles: targets and tools in cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Microparticles and acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Intercellular communication: diverse structures for exchange of genetic information

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Redox-dependent downregulation of Rho by Rac.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho GTPase function in development: how in vivo models change our view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Pulmonary vascular involvement in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Actin' up: RhoB in cancer and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Critical role of Cdc42 in mediating endothelial barrier protection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Microparticles, vascular function, and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

ROCK I-mediated activation of NF-kappaB by RhoB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

HMG-CoA Reductase Inhibitors Decrease Angiotensin II–Induced Vascular Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Different effects of smoke from heavy and light cigarettes on the induction of bronchial smooth muscle hyperresponsiveness in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Mechanisms of disease: pulmonary arterial hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho-kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Role of GTPases in control of microvascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Involvement of Rho kinase in the pathogenesis of acute pulmonary embolism-induced polystyrene microspheres in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Opposing Effects of the Angiopoietins on the Thrombin-Induced Permeability of Human Pulmonary Microvascular Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Involvement of Rho kinase in endothelial barrier maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho GTPases in cancer cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Geranylgeranylation facilitates proteasomal degradation of rho G-proteins in human trabecular meshwork cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Increased RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells by lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Simvastatin as a treatment for pulmonary hypertension trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rho GTPases and the regulation of endothelial permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

The ADMA/DDAH pathway is a critical regulator of endothelial cell motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-kappaB signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Atorvastatin in pulmonary arterial hypertension (APATH) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

Simvastatin and sildenafil combine to attenuate pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.09.004

10.1016/J.VPH.2012.09.004

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference